Biolojic Design

Human Antibody Therapeutics

Health Tech & Life Sciences
Active
Seed Rehovot, Israel Founded 2010
Last updated 2026-06-18
Total raised
$4.0M
Last: 2025-03
Stage
Seed
Founded
2010
Headcount
94
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases. Biolojic Design has developed a new tool to re-engineer antibodies to bind new epitopes in a process known as re-epitoping. This technology has been shown to yield functional antibodies in difficult targets. Using proprietary algorithms, the company identifies an existing antibody that can be re-epitoped to bind the desired target. The antibody template is then engineered in an iterative computational and experimental approach to bind the desired epitope with high affinity. In 2014, Biolojic partnered with AstraZeneca's MedImmune LLC Biologics unit to discover antibodies for undisclosed targets selected by MedImmune, using Biolojic's computational and biochemical tools.

Funding history · 3 rounds · $4.0M total

2025-03
$7.5M
2023-01

Q&A

What is Biolojic Design's primary focus?
Biolojic Design is a biopharmaceutical company focused on developing human antibody-based therapeutics for cancer and other diseases.
Where is Biolojic Design headquartered?
Biolojic Design is headquartered in Rehovot, Center District, Israel, with an additional office in Boston, MA, USA.
When was Biolojic Design founded?
Biolojic Design was founded in November 2010.
How many employees does Biolojic Design have?
Biolojic Design has 51-200 employees.
What is Biolojic Design's core technology?
Biolojic Design has developed a new tool to re-engineer antibodies to bind new epitopes, a process known as re-epitoping, using proprietary algorithms and an iterative computational and experimental approach.
What was Biolojic Design's most recent funding round?
In March 2025, Biolojic Design secured $7,500,000 in a funding round.
Which investors participated in Biolojic Design's January 2021 funding round?
OurCrowd and aMoon Fund participated in Biolojic Design's funding round in January 2021.
Who is the Founder and CEO of Biolojic Design?
Professor Yanay Ofran is the Founder and CEO of Biolojic Design.

Team · 2

Founder · Founder & CEO
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital HealthcareMedical Decision Support
Technologies
BiologicalsMoleculesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B

Highlights

1 PatentsVerified

Tags

bioconvergencetherapeuticsbioinformaticsdecision-supportnanotechnologyroboticsdigital-healthcaredrug-discoveryimmunologyhealthcarecancer-therapyantibodiesartificial-intelligencepharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)